why choose us

First received: January 20, 2023

Clinical Trial: A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Hepatitis B

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AHB-137 with Single Ascending Doses and Multiple Doses in Healthy Volunteers and Init

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of AHB-137 subcutaneous injection in healthy volunteers and in chronic hepatitis B (CHB) patients after single and multiple doses.In addition, the study will evaluate the initial antiviral efficacy of AHB-137 in CHB patients following a multiple dosing regimen.

Read more